Add to Cart View Cart/Checkout More Products

STABILITY AND COMPATIBILITY STUDIES CD

Permanent storage and easy retrieval of Journal articles and formulations.
Only $95 per CD.

STABILITY AND COMPATIBILITY STUDIES CD
  • Print Journal articles in color from the pdf file for your marketing needs.
  • Eliminate long searches through past issues for articles and formulations.
This CD contains the following articles listed by volume, issue and page number:

STABILITIES, COMPATIBILITIES RELATED ARTICLES
TitleVolume/IssuePage
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Vol. 22 No. 6 504
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Vol. 22 No. 6 516
Stability of Tranexamic Acid Mouth Rinse Vol. 22 No. 5 412
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Vol. 22 No. 5 417
A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier Vol. 22 No. 5 424
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Vol. 22 No. 4 303
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension Vol. 22 No. 4 326
Kinetics of Tetracaine Solvolysis in Propylene Glycol Vol. 22 No. 4 329
Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit Vol. 22 No. 4 335
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes Vol. 22 No. 4 340
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals Vol. 22 No. 3 240
Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations Vol. 22 No. 3 247
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Vol. 22 No. 3 252
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Vol. 22 No. 2 129
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions Vol. 22 No. 2 164
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Vol. 22 No. 1 66
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Vol. 22 No. 1 76
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Vol. 22 No. 1 86
Feline Transdermal Formulation Considerations Vol. 21 No. 6 446
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Vol. 21 No. 6 500
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Vol. 21 No. 5 426
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt Vol. 21 No. 5 430
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Vol. 21 No. 5 436
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Vol. 21 No. 4 322
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Vol. 21 No. 4 334
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4 Vol. 21 No. 4 339
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Vol. 21 No. 4 347
Basics of Sterile Compounding: Manipulating Peptides and Proteins Vol. 21 No. 3 223
Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil Vol. 21 No. 3 240
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes Vol. 21 No. 3 251
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions Vol. 21 No. 3 255
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers Vol. 21 No. 2 150
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date Vol. 21 No. 2 154
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions Vol. 21 No. 2 160
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Vol. 21 No. 2 164
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Vol. 21 No. 2 171
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Vol. 21 No. 1 66
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Vol. 21 No. 1 76
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Vol. 21 No. 1 83
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Vol. 20 No. 6 495
Stability of Fentanyl Citrate in Polyolefin Bags Vol. 20 No. 6 514
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature Vol. 20 No. 6 521
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Vol. 20 No. 5 356
Quality Control Analytical Methods: Method Validation Vol. 20 No. 5 381
Basics of Compounding: Clinical Pharmaceutics, Part 1 Vol. 20 No. 5 389
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Vol. 20 No. 5 416
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Vol. 20 No. 5 421
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Vol. 20 No. 5 426
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Vol. 20 No. 5 435
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Vol. 20 No. 5 438
Basics of Compounding: Compounding Films Vol. 20 No. 4 298
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Vol. 20 No. 4 328
Stability of Ampicillin in Normal Saline and Buffered Normal Saline Vol. 20 No. 4 338
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Vol. 20 No. 4 343
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Vol. 20 No. 4 347
Does Your Drug Expertise Include Clinical Pharmaceutics? Vol. 20 No. 3 202
Basics of Compounding: Special Capsules Vol. 20 No. 3 209
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Vol. 20 No. 3 217
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Vol. 20 No. 3 236
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Vol. 20 No. 3 247
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Vol. 20 No. 3 257
Basics of Compounding: Capsules Vol. 20 No. 2 125
Formulation and Stability of Solutions Vol. 20 No. 2 137
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Vol. 20 No. 2 159
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Vol. 20 No. 2 164
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Vol. 20 No. 2 167
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Vol. 20 No. 1 6
Basic Principles of Lyophilization, Part 2 Vol. 20 No. 1 20
Formulation and Stability of Solutions Vol. 20 No. 1 41
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care Vol. 20 No. 1 58
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation Vol. 20 No. 1 63
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Vol. 20 No. 1 81
Basic Principles of Lyophilization, Part 1 Vol. 19 No. 6 471
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Vol. 19 No. 6 521
Novel Approaches to Topical Psoriasis Therapy Vol. 19 No. 5 357
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Vol. 19 No. 5 383
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Vol. 19 No. 5 414
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Vol. 19 No. 5 420
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Vol. 19 No. 5 428
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Vol. 19 No. 5 432
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Vol. 19 No. 4 280
Stability of Prednisone in Oral Mix Suspending Vehicle Vol. 19 No. 4 337
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Vol. 19 No. 4 344
Stability of Metronidazole Suspensions Vol. 19 No. 3 248
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Vol. 19 No. 3 261
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Vol. 19 No. 3 268
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Vol. 19 No. 1 38
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Vol. 19 No. 1 70
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Vol. 19 No. 1 73
Stability of Suspensions: Theoretical and Practical Considerations before Compounding Vol. 19 No. 1 78
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date Vol. 18 No. 6 456
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Vol. 18 No. 6 479
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils Vol. 18 No. 6 516
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Vol. 18 No. 5 418
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Vol. 18 No. 5 427
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers Vol. 18 No. 5 432
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 4 345
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 4 348
Investigation of Physical and Chemical Stability of an Ointment with Herbals Vol. 18 No. 3 248
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 3 253
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Vol. 18 No. 3 256
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride Vol. 18 No. 2 152
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Vol. 18 No. 2 169
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C Vol. 18 No. 1 78
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Vol. 17 No. 6 508
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes Vol. 17 No. 6 515
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Vol. 17 No. 5 436
Basics of Compounding: Foam Dosage Forms Vol. 17 No. 4 312
Stability of Captopril in SyrSPend SF Vol. 17 No. 4 336
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Vol. 17 No. 4 344
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs Vol. 17 No. 4 347
Basics of Compounding: Potency and Stability Testing Vol. 17 No. 3 220
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Vol. 17 No. 3 238
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Vol. 17 No. 3 254
Basics of Compounding: Repackaging, Part 2 Vol. 17 No. 2 136
Stability of Rifampin in SyrSpend SF Vol. 17 No. 2 162
Stability of Minoxidil in Espumil Foam Base Vol. 17 No. 2 165
Beyond-use Date: Establishment and Maintenance Vol. 16 No. 6 471
Stability of Ursodiol in SyrSpend SF Cherry Flavored Vol. 16 No. 6 510
Stability of Propranolol Hydrochloride in SyrSpend SF Vol. 16 No. 6 513
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations Vol. 16 No. 6 516
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Vol. 16 No. 5 428
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Vol. 16 No. 4 342
Stability of Gabapentin in SyrSpend SF Vol. 16 No. 4 347
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification Vol. 16 No. 3 230
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste Vol. 16 No. 3 258
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Vol. 16 No. 2 164
Stability of Vancomycin in SyrSpend SF Vol. 16 No. 2 167
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method Vol. 16 No. 2 170
Chemical Stability of Pentoxifylline in a Topical Cream Vol. 16 No. 1 80
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Vol. 16 No. 1 82
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Vol. 16 No. 1 62
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3 Vol. 15 No. 6 488
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Vol. 15 No. 6 515
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Vol. 15 No. 5 428
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations Vol. 15 No. 5 435
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Vol. 15 No. 4 344
Stability of Ertapenem in an Elastomeric Infusion Device Vol. 15 No. 3 252
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Vol. 15 No. 3 255
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Vol. 15 No. 3 259
Drug Compatibility and Stability in Dextrose vs Saline Vol. 15 No. 3 190
Basics of Compounding: Basics of Compounding with Complex Organic Molecules Vol. 15 No. 3 234
Basics of Compounding: Basics of Compounding with Inorganic Salts Vol. 15 No. 2 146
Nifedpine in Compounded Oral and Topical Preparations Vol. 15 No. 2 166
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes Vol. 15 No. 2 170
Maillard Reactions in Pharmaceutical Formulations and Human Health Vol. 15 No. 1 32
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Vol. 15 No. 1 74
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form Vol. 15 No. 1 78
Stability of Venlafaxine Immediate-Release Suspensions Vol. 15 No. 1 81
PreScription: Compounding with Manufactured Products Vol. 14 No. 6 448
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Vol. 14 No. 6 522
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Vol. 14 No. 5 430
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Vol. 14 No. 5 436
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents Vol. 14 No. 4 284
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Vol. 14 No. 4 342
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Vol. 14 No. 4 346
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Vol. 14 No. 3 232
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration Vol. 14 No. 3 250
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Vol. 14 No. 2 118
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Vol. 14 No. 2 160
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle Vol. 14 No. 1 76
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam Vol. 14 No. 1 78
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Vol. 14 No. 1 82
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding Vol. 13 No. 6 525
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Vol. 13 No. 6 564
Chemical Stability of Scopolamine Hydrobromide Nasal Solution Vol. 13 No. 5 438
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms Vol. 13 No. 5 445
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Vol. 13 No. 3 250
Stability of Pergolide Mesylate Oral Liquid at Room Temperature Vol. 13 No. 3 254
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers Vol. 13 No. 2 162
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions Vol. 13 No. 2 166
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule Vol. 13 No. 2 170
Identifying the Criteria of a Valid Stability Study Vol. 13 No. 1 32
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Vol. 13 No. 1 78
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Vol. 12 No. 5 456
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Vol. 12 No. 5 460
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Vol. 12 No. 5 463
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Vol. 12 No. 6 524
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties Vol. 12 No. 6 550
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Vol. 12 No. 6 553
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Vol. 12 No. 6 558
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Vol. 12 No. 4 344
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Vol. 12 No. 4 372
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Vol. 12 No. 4 368
Chemical Stability of Naltrexone Hydrochloride Injection Vol. 12 No. 3 274
Dilution and Compounding of Ziconotide for Intrathecal Administration Vol. 12 No. 3 200
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Vol. 12 No. 3 276
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Vol. 12 No. 2 130
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Vol. 12 No. 2 156
Chemical Stability of Tramadol Hydrochloride Injection Vol. 12 No. 2 161
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting Vol. 12 No. 2 163
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Vol. 12 No. 2 170
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method Vol. 12 No. 1 50
Room Temperature Stability of Injectable Succinylcholine Dichloride Vol. 12 No. 1 83
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Vol. 11 No. 6 520
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Vol. 11 No. 5 426
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form Vol. 11 No. 4 347
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Vol. 11 No. 3 259
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Vol. 11 No. 2 164
Pediatric Oral Formulations: A Continual Challenge Vol. 11 No. 1 17
Sevelamer Suspension in Children with End-Stage Renal Disease Vol. 11 No. 1 20
Chemical Stability of Desonide in Ear Drops Vol. 11 No. 1 79
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Vol. 11 No. 1 82
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Vol. 10 No. 5 396
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free Vol. 10 No. 4 318
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729> Vol. 10 No. 4 309
Stability of Memantine in an Extemporaneously Prepared Oral Liquid Vol. 10 No. 4 316
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Vol. 10 No. 3 230
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Vol. 10 No. 3 234
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Vol. 10 No. 3 237
Chemical Stability of Diclofenac Sodium Injection Vol. 10 No. 2 154
Extended Stability of Oxytocin in Common Infusion Solutions Vol. 10 No. 2 156
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Vol. 10 No. 1 69
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Vol. 10 No. 1 74
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags Vol. 9 No. 6 482
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Vol. 9 No. 6 484
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration Vol. 9 No. 5 396
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion Vol. 9 No. 5 399
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Vol. 9 No. 5 402
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Vol. 9 No. 4 320
Stability of Nebulizer Admixtures Vol. 9 No. 4 323
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Vol. 9 No. 3 235
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Vol. 9 No. 3 238
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form Vol. 9 No. 2 165
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature Vol. 9 No. 1 72
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Vol. 9 No. 1 82
Stability of Extemporaneous Oral Ribavirin Liquid Preparation Vol. 8 No. 6 486
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Vol. 8 No. 6 489
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Vol. 8 No. 6 492
Book and Literature Reviews Vol. 8 No. 5 324
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Vol. 8 No. 5 398
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags Vol. 8 No. 5 404
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Vol. 8 No. 3 228
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Vol. 8 No. 3 231
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Vol. 8 No. 2 147
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
Vancomycin HCl and Heparin Sodium Injection Vol. 8 No. 1 60
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Vol. 7 No. 5 386
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Vol. 7 No. 5 389
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Vol. 7 No. 3 233
Stability of Clindamycin Phosphate in AutoDose Infusion System Bags Vol. 7 No. 2 149
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 2 152
Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis Vol. 7 No. 2 155
Stability of Glycopyrrolate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 7 No. 1 65
Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes Vol. 7 No. 1 68
Chemical Stability of Furosemide in Minibags and Polypropylene Syringes Vol. 6 No. 6 468
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 6 475
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes Vol. 6 No. 6 471
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 5 388
Effect of Freezing, Long-Term Storage, and Microwave Thawing on the Stability of Cefepime in 5% Dextrose Infusion Polyvinyl Chloride Bags Vol. 6 No. 5 391
Chemical Stability of Dexamethasone Sodium Phosphate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes Vol. 6 No. 5 395
Stability of Tubocurarine Chloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 4 308
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Vol. 6 No. 4 311
Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storage in 1-mL Tuberculin Polypropylene Syringes for Pediatric Use Vol. 6 No. 4 316
pH and Osmolarity, A Review of Vol. 6 No. 3 216
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags Vol. 6 No. 3 226
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Vol. 6 No. 3 230
Stability of Cefotaxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 6 No. 3 234
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags Vol. 6 No. 2 152
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules Vol. 6 No. 2 155
Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes Vol. 6 No. 1 62
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes Vol. 6 No. 1 66
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Vol. 6 No. 1 70
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes Vol. 6 No. 1 74
Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion Vol. 5 No. 6 456
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets Vol. 5 No. 6 480
Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes Vol. 5 No. 6 482
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 5 No. 5 394
Assessment of the Stability of Teicoplanin in Intravenous Infusions Vol. 5 No. 5 397
Analytical Testing Facilities and Products Vol. 5 No. 4 284
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Vol. 5 No. 4 314
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions Vol. 5 No. 4 323
Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study Vol. 5 No. 3 195
Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 3 230
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Vol. 5 No. 3 232
Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes Vol. 5 No. 2 148
Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 2 151
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate Vol. 5 No. 2 153
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Vol. 5 No. 1 9
Sterile-Product Preparations: Mix or Buy? Vol. 5 No. 1 59
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Vol. 5 No. 1 69
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 73
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 75
Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate Vol. 4 No .6 476
Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 4 No .6 480
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes Vol. 4 No .6 482
Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 4 No. 5 396
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets Vol. 4 No. 5 398
Short Communication: Compounding for Implantable Pumps Vol. 4 No. 4 280
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection Vol. 4 No. 4 296
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection Vol. 4 No. 4 298
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs Vol. 4 No. 4 318
Three Drug Stability Lives Vol. 4 No. 3 190
Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs Vol. 4 No. 3 225
Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation Vol. 4 No. 3 229
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography Vol. 4 No. 3 233
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution Vol. 4 No. 2 146
Effect of Some Antioxidants on the Color Change of White Lotion Vol. 4 No. 2 154
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration Vol. 4 No. 2 150
Compounding Intrathecal Medications Vol. 4 No. 1 24
Particulates in Parenterals Vol. 4 No. 1 43
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection Vol. 4 No. 1 66
Naratriptan HCl in Extemporaneously Compounded Oral Suspensions Vol. 4 No. 1 69
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids Vol. 4 No. 1 72
Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure Vol. 3 No. 6 488
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C Vol. 3 No. 5 412
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II Vol. 3 No. 5 415
Extemporaneous Formulations in Pediatric Patients Vol. 3 No. 4 274
Parenteral Admixture with Y-Site Administration Vol. 3 No. 4 303
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution Vol. 3 No. 4 306
Veterinary Flavor Suggestions Vol. 3 No. 3 186
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Vol. 3 No. 3 235
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Vol. 3 No. 3 241
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography Vol. 3 No. 3 239
Analysis of Extemporaneous Alprostadil Formulations Vol. 3 No. 2 148
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags Vol. 3 No. 2 156
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks Vol. 3 No. 1 56
Stability of Four Commercial Products Delivered by Mail Order Vol. 3 No. 1 59
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital Vol. 3 No. 1 64
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature Vol. 3 No. 1 67
Chemical Stability of Meperidine Hydrochloride in Polypropylene Syringes Vol. 2 No. 6 463
Stability of Sufentanil in a Syringe Pump Under Simulated Epidural Infusion Vol. 2 No. 6 466
Stability of Albuterol in Continuous Nebulization Vol. 2 No. 5 394
The Stability of Amphotericin B in a Mixture of Fungizone and Optimoist Vol. 2 No. 4 311
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form Vol. 2 No. 4 314
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Vol. 2 No. 4 318
Stability of Lorazepam in 5% Dextrose Injection Vol. 2 No. 4 322
Paclitaxel Compatibility with IV Express Filter Unit Vol. 2 No. 3 243
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL Vol. 2 No. 3 246
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 2 No. 2 168
Stability of Indomethacin in 0.9% Sodium Chloride Injection Vol. 2 No. 2 170
The pH Value of Urea Solutions in Purified Water Vol. 2 No. 1 76
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion Vol. 2 No. 1 79
Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base Vol. 2 No. 1 89
Basic Statistical Concepts for Evaluating Pharmaceutical Compounding Literature: Part 1.Statistics for Continuous Data and Stability Studies Vol. 1 No. 6 395
Stability of Two Concentrations of Heparin Sodium Prefilled in CADD-Micro Pump Syringes Vol. 1 No. 6 433
Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 6 435
Short-Term Stability of Atenolol in Oral Liquid Formulations Vol. 1 No. 6 437
Stability of Clonazepam Suspension in HSC Vehicle Vol. 1 No. 6 440
Drug Stability and Compatibility: Special Considerations for Home Health Care Vol. 1 No. 5 301
Chemical Stability of Amiodarone Hydrochloride in Intravenous Fluids Vol. 1 No. 5 347
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms Vol. 1 No. 5 349
The Stability of Lisinopril as an Extemporaneous Syrup Vol. 1 No. 5 352
Compatibility of Vancomycin Hydrochloride and Famotidine in 5% Dextrose Injection Vol. 1 No. 5 354
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions Vol. 1 No. 5 356
Stability of Ceftriaxone Sodium When Mixed with Metronidazole Injection Vol. 1 No. 4 280
Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes Vol. 1 No. 4 282
Parenteral Admixture Incompatibilities:An Introduction Vol. 1 No. 3 165
Physical Stability of Urea Topical Formulations Vol. 1 No. 3 168
The Formulation Development and Stability of Spironolactone Suspension Vol. 1 No. 3 195
The Formulation Development and Stability of Metronidazole Suspension Vol. 1 No. 3 200
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections Vol. 1 No. 3 206
Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 3 208
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Vol. 1 No. 2 118
The Compatibility of Common Respiratory Therapy Drug Combinations Vol. 1 No. 2 121
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs Vol. 1 No. 2 123
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture Vol. 1 No. 2 125
Stability of Allopurinol Suspension Compounded from Tablets Vol. 1 No. 2 128
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 2 132
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion Vol. 1 No. 1 49